Table 1.
Source of PC-EVs | Culture Condition | PC-EV Cargo | Beneficial or Adverse Effect | Reference |
---|---|---|---|---|
PC-EVs from retinal PCs | Normal | CTGF, CD44 | Protected lung tissue and improved pulmonary function EVs protected VEC function |
[47] |
Hypoxia | circEhmt1 | Protected endothelial cells from HG-induced injury | [48] | |
Diabetic and non-diabetic mouse | cPWWP2A | Controlled diabetes mellitus-induced microvascular dysfunction | [49] | |
PC-EVs in brain | Stimulated with PDGF-BB | BDNF, bFGF, BNGF, VEGF, PLGF | EV release of BDNF, bFGF, bNGF, VEGF, PLGF Neuroprotection, angiogenesis |
[41,46] |
Stimulated with LPS | IL-6, IL-8, IL-10, MCP-1, |
Vascular and neuronal inflammation | [41] | |
PC-EVs in brain | Normal | miR-26a, miR-143, miR 122-5p, miR-6240, miR-122-5p, miR-181a, miR-21, miR-29a, let-7c-5p, let-7a-5p miR-1285 | Biomarkers and treatment of hypertension | [43] |
PC-EVs in muscle | Stimulation with H2O2 | antioxidants and anti-inflammatory compounds | Anti-oxidative Anti-inflammatory Extracellular matrix remodeling |
[50] |